Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 975 of 3284 entries
View as:

Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey

Phase: N/A Priority: Normal
NCT ID: NCT00916513 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00679783 Org: User:
Start: 07/08/08 End: 07/20/22 Due: 07/20/23

A Study to Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04949438 Org: User:
Start: 01/21/22 End: 03/04/22 Due: 03/04/23

A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females

Phase: N/A Priority: Normal
NCT ID: NCT01330758 Org: User:
Start: 04/30/11 End: 05/31/11 Due: 05/31/12

Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®

Phase: N/A Priority: Normal
NCT ID: NCT01048333 Org: User:
Start: 01/31/10 End: 05/31/10 Due: 05/31/11

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00099437 Org: User:
Start: 02/13/05 End: 12/31/25 Due: 12/31/26

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT06473779 Org: User:
Start: 09/30/24 End: 06/30/27 Due: 06/30/28

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Phase: N/A Priority: Normal
NCT ID: NCT05742802 Org: User:
Start: 03/06/23 End: 08/17/26 Due: 08/17/27

Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00240357 Org: User:
Start: 02/28/03 End: - Due: -

An Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516

Phase: N/A Priority: Normal
NCT ID: NCT00892944 Org: User:
Start: 04/30/09 End: 10/31/09 Due: 10/31/10

Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00930865 Org: User:
Start: 07/31/09 End: 09/30/09 Due: 09/30/10

Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

Phase: N/A Priority: Normal
NCT ID: NCT07024680 Org: User:
Start: 03/31/25 End: 10/30/25 Due: 10/30/26

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03036124 Org: User:
Start: 02/08/17 End: 07/17/19 Due: 07/17/20

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

Phase: N/A Priority: Normal
NCT ID: NCT03189875 Org: User:
Start: 06/28/17 End: 11/18/22 Due: 11/18/23

A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels

Phase: N/A Priority: Normal
NCT ID: NCT01069822 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00085891 Org: User:
Start: 06/30/04 End: 09/30/05 Due: 09/30/06

Bioequivalence Study

Phase: N/A Priority: Normal
NCT ID: NCT01874080 Org: User:
Start: 06/30/13 End: 07/31/13 Due: 07/31/14

Nexium Capsules LDA Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01729182 Org: User:
Start: 01/01/13 End: 03/09/17 Due: 03/09/18

Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01192659 Org: User:
Start: 05/31/10 End: 12/31/15 Due: 12/31/16

Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386

Phase: N/A Priority: Normal
NCT ID: NCT00832169 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

An Open-Label, Dose-Escalation Study of AZD2461

Phase: N/A Priority: Normal
NCT ID: NCT01247168 Org: User:
Start: 11/30/10 End: 05/31/11 Due: 05/31/12

AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01584739 Org: User:
Start: 06/30/12 End: 11/30/12 Due: 11/30/13

Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06053424 Org: User:
Start: 09/25/23 End: 10/08/24 Due: 10/08/25

Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00306540 Org: User:
Start: 12/31/04 End: 08/31/08 Due: 08/31/09

STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

Phase: N/A Priority: Normal
NCT ID: NCT00654537 Org: User:
Start: 04/30/01 End: 10/31/04 Due: 10/31/05